Cobra venom neutralised by common blood-thinning drug Heparin

Getty Images A Mozambique spitting cobraGetty Images

A drug commonly prescribed to slender body can be repurposed as a cheap remedy to snake poison, a team of scientists based in Australia, Canada, Costa Rica and the UK has discovered.

Injuries kill about 138, 000 people a year, mainly in poorer remote places in reduced- and middle-income countries in Africa, South and South East Asia.

More than 400, 000 people develop apoptosis, when the tissues around the bit dies and turns dark.

In parts of Africa and India, creatures are responsible for the majority of bites. Additionally, anticoagulant can neutralize the necrosis-causing poisons in some spewing creatures ‘ venom.

The drug does not work against all types of snake venom, but the scientists claim that it is more affordable and flexible than current antivenoms, many of which only work against one specific type of snake and never stop necrosis.

The next step may be people studies after the drug has already been tested on mice.

‘ Global struggle ‘

Our finding, according to older study author Prof. Greg Neely from the University of Sydney, may significantly decrease the terrible injuries brought on by snake bites. It could also decrease the venom, which may increase survival rates.

Our study sought to identify what biological agents, such as toxins and venom, interact with the poison to cause this apoptosis and death. This is because natural agents like toxins and venom all require some collaboration from the host side, the animal side.

What we’re finding is that when we take venoms from quite different types, there are only a few ways that they interact with human tissue.

One of the great things in science is that we believe we can identify four or five different ways in which cells in turn interact with venom, and then create general antidotes that can stop large groups of species.

” We hope that the new snake remedy we discovered will be a tool in the international effort to reduce snakebite death and injury in some of the world’s poorest communities.”

” Lasting illness”

Direct writer, PhD student Tian Du, also from the University of Sydney, called it a great step ahead.

” Heparin is cheap, widespread and a World Health Organization-listed necessary medicine”, she said.

It could be released fairly fast as a affordable, safe, and effective drug for treating snake bites following successful human trials.

According to another scientist, Prof. Nicholas Casewell, head of the Liverpool School of Tropical Medicine’s Center for Snakebite Research and Interventions,” Injuries continue to be the most fatal of the neglected tropical diseases, with its load disproportionately burdening rural populations in reduced- and middle-income places.

Our findings are exciting because current antivenoms are largely ineffective against severe local envenoming, which involves painful progressive blistering, blistering, and/or tissue necrosis around the bite site.

” This can lead to loss of limb function, amputation and lifelong disability”.